CDKN2A and cancer: Of the 82 unique prognostic biomarkers identified, meta-analyses showed several promising biomarkers, including COX-2, PAK-1, p14ARF, PD-L1, MET, LC3B and LGR5, associated to each hallmark of cancer feature.